Pharmacogenomics: Tailoring drug therapies for improved outcomes

While research from as far back as the 1960's indicates that genetic variations are directly responsible for different medication responses, only recently have the reduced costs of testing made the benefits of pharmacogenomics (PGx) available to many patients. While the list of clinical trials and PGx tests is continually expanding, many medications are not yet associated with clinically useful guidance.

Download White Paper

You may also like:

Blog Post

It has been both good news and yet more uncertainty recently in the effort to keep COVID-19 from becoming a pandemic. On the upside, pharmaceutical manufacturer Moderna

View Blog Post
Blog Post

Recently, I participated in the annual meeting of one of my favorite organizations: The American Society of Automation in Pharmacy (ASAP). ASAP's mission is to foster ...

View Blog Post
Blog Post

An outbreak of coronavirus in Wuhan, China, has captured international attention, killing 82 in China (as of January 27 reports)...

View Blog Post

Filter by Type

Sign up to receive the latest news and information!

Sign Up